MOACM
NKTR icon

Mutual of America Capital Management’s Nektar Therapeutics NKTR Stock Holding History

Mutual of America Capital Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,580
Closed -$27.2K – 1488
2023
Q1 		$27.2K Sell
2,580
-46
-2% -$1.39K ﹤0.01% 1459
2022
Q4 		$89K Buy
2,626
+140
+6% +$6.78K ﹤0.01% 1438
2022
Q3 		$119K Buy
2,486
+400
+19% +$23.8K ﹤0.01% 1493
2022
Q2 		$119K Buy
2,086
+313
+18% +$19.7K ﹤0.01% 1468
2022
Q1 		$143K Buy
1,773
+92
+5% +$13.6K ﹤0.01% 1437
2021
Q4 		$341K Sell
1,681
-9,122
-84% -$1.98M ﹤0.01% 1203
2021
Q3 		$2.91M Buy
10,803
+191
+2% +$45.9K 0.03% 801
2021
Q2 		$2.73M Sell
10,612
-253
-2% -$70K 0.03% 846
2021
Q1 		$3.26M Sell
10,865
-413
-4% -$129K 0.03% 742
2020
Q4 		$2.88M Buy
11,278
+165
+1% +$42.6K 0.03% 759
2020
Q3 		$2.77M Buy
11,113
+181
+2% +$56.9K 0.04% 657
2020
Q2 		$3.8M Buy
10,932
+21
+0.2% +$6.55K 0.05% 487
2020
Q1 		$2.92M Buy
10,911
+279
+3% +$86.3K 0.05% 518
2019
Q4 		$3.44M Buy
10,632
+9,069
+580% +$2.63M 0.04% 640
2019
Q3 		$427K Buy
1,563
+17
+1% +$6.24K 0.01% 1127
2019
Q2 		$825K Sell
1,546
-7
-0.5% -$3.51K 0.01% 1096
2019
Q1 		$783K Buy
1,553
+8
+0.5% +$4.74K 0.01% 1098
2018
Q4 		$762K Buy
1,545
+65
+4% +$39.2K 0.01% 1085
2018
Q3 		$1.35M Buy
1,480
+97
+7% +$82.8K 0.02% 1037
2018
Q2 		$1.01M Sell
1,383
-5,316
-79% -$6.13M 0.02% 1093
2018
Q1 		$10.7M Buy
6,699
+2,573
+62% +$3.31M 0.17% 98
2017
Q4 		$3.7M Buy
+4,126
New +$2.44M 0.06% 556

Other funds holding NKTR

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Mutual of America Capital Management's NKTR Position: Q2 2023 in Review

Mutual of America Capital Management sold out of Nektar Therapeutics (NKTR) in Q2 2023, closing a stake of 2,580 shares — an estimated $27.2K sold.

Mutual of America Capital Management first reported a position in NKTR in Q4 2017 and held it in 22 quarters. The position peaked at $10.7M in Q1 2018. 146 funds tracked by Wall St. Rank hold NKTR as of Q2 2023.

  • Mutual of America Capital Management reported no remaining Nektar Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Mutual of America Capital Management sold 2,580 Nektar Therapeutics shares in Q2 2023, an estimated $27.2K.
  • Mutual of America Capital Management first reported a position in Nektar Therapeutics in Q4 2017 and held it in 22 quarters.
  • Mutual of America Capital Management's Nektar Therapeutics position peaked at $10.7M in Q1 2018.
  • 146 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2023.

Based on Mutual of America Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.